eli lilly retatrutide lawsuit asks to join over compounded versions of its weight-loss drugs Lilly, Novo fight surge in

Does it target fine lines and wrinkles

When combined with insulin or sulfonylureas, dose adjustments of these medications may be necessary to reduce the risk of hypoglycaemia, and should only be made under healthcare professional supervision

But heres the toxicology blind spot: oral small-molecule GLP-1 drugs create a very different safety landscape than injectable peptides

According to a 2025 survey by KFF, less than 1 in 4 employers currently cover GLP-1s when used primarily for weight management

Fridays Health takes a holistic approach to GLP-1 weight loss by pairing medication with a fitness app, dietitian access, and insurance support a combination that few competitors offer at this pr